Compare Heron Therapeutics Inc (HRTX) vs Marqeta Inc (MQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Marqeta Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Marqeta Inc trades at $15.52 (market cap $1.62B). The key difference: Marqeta Inc is far larger — about 26.4× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | MQ | |
|---|---|---|
Market Cap | $61.47M | $1.62B |
Sector | Health | Technology |
52-Week High | $1.49 | $26.00 |
52-Week Low | $0.32 | $15.04 |
Enterprise Value | $168.21M | $935.36M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →
